Table of Contents

2019-2024 Global Adult and Pediatric Vaccines Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adult and Pediatric Vaccines Market Size 2014-2024
2.1.2 Adult and Pediatric Vaccines Market Size CAGR by Region
2.2 Adult and Pediatric Vaccines Segment by Type
2.2.1 Adult Vaccines
2.2.2 Pediatric Vaccines
2.3 Adult and Pediatric Vaccines Market Size by Type
2.3.1 Global Adult and Pediatric Vaccines Market Size Market Share by Type (2014-2019)
2.3.2 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (2014-2019)
2.4 Adult and Pediatric Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Medical Care Centers
2.4.3 Others
2.5 Adult and Pediatric Vaccines Market Size by Application
2.5.1 Global Adult and Pediatric Vaccines Market Size Market Share by Application (2014-2019)
2.5.2 Global Adult and Pediatric Vaccines Market Size Growth Rate by Application (2014-2019)

3 Global Adult and Pediatric Vaccines by Players
3.1 Global Adult and Pediatric Vaccines Market Size Market Share by Players
3.1.1 Global Adult and Pediatric Vaccines Market Size by Players (2017-2019)
3.1.2 Global Adult and Pediatric Vaccines Market Size Market Share by Players (2017-2019)
3.2 Global Adult and Pediatric Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Adult and Pediatric Vaccines by Regions
4.1 Adult and Pediatric Vaccines Market Size by Regions
4.2 Americas Adult and Pediatric Vaccines Market Size Growth
4.3 APAC Adult and Pediatric Vaccines Market Size Growth
4.4 Europe Adult and Pediatric Vaccines Market Size Growth
4.5 Middle East & Africa Adult and Pediatric Vaccines Market Size Growth

5 Americas
5.1 Americas Adult and Pediatric Vaccines Market Size by Countries
5.2 Americas Adult and Pediatric Vaccines Market Size by Type
5.3 Americas Adult and Pediatric Vaccines Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Adult and Pediatric Vaccines Market Size by Countries
6.2 APAC Adult and Pediatric Vaccines Market Size by Type
6.3 APAC Adult and Pediatric Vaccines Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Adult and Pediatric Vaccines by Countries
7.2 Europe Adult and Pediatric Vaccines Market Size by Type
7.3 Europe Adult and Pediatric Vaccines Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Adult and Pediatric Vaccines by Countries
8.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type
8.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Adult and Pediatric Vaccines Market Forecast
10.1 Global Adult and Pediatric Vaccines Market Size Forecast (2019-2024)
10.2 Global Adult and Pediatric Vaccines Forecast by Regions
10.2.1 Global Adult and Pediatric Vaccines Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Adult and Pediatric Vaccines Forecast by Type
10.8 Global Adult and Pediatric Vaccines Forecast by Application

11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 Company Details
11.1.2 Adult and Pediatric Vaccines Product Offered
11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 GlaxoSmithKline News
11.2 Sanofi
11.2.1 Company Details
11.2.2 Adult and Pediatric Vaccines Product Offered
11.2.3 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Sanofi News
11.3 Merck
11.3.1 Company Details
11.3.2 Adult and Pediatric Vaccines Product Offered
11.3.3 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Merck News
11.4 Novartis
11.4.1 Company Details
11.4.2 Adult and Pediatric Vaccines Product Offered
11.4.3 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Adult and Pediatric Vaccines Product Offered
11.5.3 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 AstraZeneca
11.6.1 Company Details
11.6.2 Adult and Pediatric Vaccines Product Offered
11.6.3 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 AstraZeneca News
11.7 Johnson and Johnson
11.7.1 Company Details
11.7.2 Adult and Pediatric Vaccines Product Offered
11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Johnson and Johnson News
11.8 Takeda Pharmaceutical
11.8.1 Company Details
11.8.2 Adult and Pediatric Vaccines Product Offered
11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Takeda Pharmaceutical News
11.9 Bavarian Nordic
11.9.1 Company Details
11.9.2 Adult and Pediatric Vaccines Product Offered
11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Bavarian Nordic News
11.10 LG Life Sciences
11.10.1 Company Details
11.10.2 Adult and Pediatric Vaccines Product Offered
11.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 LG Life Sciences News
11.11 Sinovac Biotech

12 Research Findings and Conclusion